TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In multiple sclerosis, inflammation can successfully be prevented, while promoting repair is still a major challenge. Microglial cells, the resident phagocytes of the central nervous system (CNS), are hematopoietic-derived myeloid cells and express the triggering receptor expressed on myeloid cells 2 (TREM2), an innate immune receptor. Myeloid cells are an accessible source for ex vivo gene therapy. We investigated whether myeloid precursor cells genetically modified to express TREM2 affect the disease course of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis. METHODS AND FINDINGS: EAE was induced in mice by immunization with a myelin autoantigen. Intravenous application of TREM2-transduced bone marrow-derived myeloid precursor cells at the EAE peak led to an amelioration of clinical symptoms, reduction in axonal damage, and prevention of further demyelination. TREM2-transduced myeloid cells applied intravenously migrated into the inflammatory spinal cord lesions of EAE-diseased mice, showed increased lysosomal and phagocytic activity, cleared degenerated myelin, and created an anti-inflammatory cytokine milieu within the CNS. CONCLUSIONS: Intravenously applied bone marrow-derived and TREM2-tranduced myeloid precursor cells limit tissue destruction and facilitate repair within the murine CNS by clearance of cellular debris during EAE. TREM2 is a new attractive target for promotion of repair and resolution of inflammation in multiple sclerosis and other neuroinflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In particular, the clearance of myelin debris by microglia is believed to be critically required to limit neuronal damage in EAE (Cignarella et al., 2020; Takahashi et al., 2007; Weinger et al., 2011).”
From SYK coordinates neuroprotective microglial responses in neurodegenerative disease (2022) · cites this paper as Takahashi et al., 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“TREM2 promotes proliferation (119), survival (119), and phagocytosis of apoptotic cells (120–122).”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundImmunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundA blast from the past: clearance of apoptotic cells regulates immune responses
Savill, J., Dransfield, I., Gregory, C., & Haslett, C. (2002) · Nature Reviews Immunology · doi:10.1038/nri957 · Cited by 1,574 · cited 1×
“Efficient removal of apoptotic cells and cellular debris by macrophages during acute injury or degenerative diseases is essential for repair of the damaged tissue, inflammation resolution, and disease recovery [11–13].”
BackgroundPerivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466 · cited 1×
“Hematopoietic-derived myeloid cells physiologically migrate into the central nervous system (CNS) not only during development, but also in adulthood, and become resident perivascular macrophages and microglia [1–3].”
BackgroundTakahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 12×
“Recently, we discovered in vitro that the microglial triggering receptor expressed on myeloid cells-2 (TREM2) stimulates phagocytosis and down-regulates inflammatory signals in microglia via the signaling adaptor molecule DAP12 [14].”
BackgroundInfluentialSelf-citationYoussef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097 · cited 1×
“Most experimental approaches in EAE aim at skewing the cytokine profile of myelin-specific TH cells from TH1 to TH2 by altered peptide ligands [43,44], hydroxymethyl-glutaryl coenzyme A reductase inhibitors (‘‘statins’’) [45], or DNA vaccination combined with gene delivery of interleukin-4 (IL-4) [46].”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 1×
“Recently, brain-derived neurospheres have been injected intravenously and have been successfully used for cell therapy of EAE inducing repair and immunomodulatory activity [48,49], but these adult neural precursors are not a suitable cellular source for broad clinical applications.”
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism
Pluchino, S., Zanotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., Martinello, M., Cattalini, A., Bergami, A., Furlan, R., et al. (2005) · Nature · doi:10.1038/nature03889 · Cited by 768
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 1×
“Furthermore, the microglial cytokine milieu determines the outcome of the inflammatory process in the animal model of MS, experimental autoimmune encephalomyelitis (EAE) [16–18].”
BackgroundSelf-citationTREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701 · cited 2×
“dendritic cells, and microglia [21].”
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · cited 1×
“Recently, it has been shown that TREM2 is expressed on macrophages infiltrating CNS tissue from the circulation, and that TREM2 acts to inhibit cytokine production by macrophages in response to several toll-like receptor ligands [28].”
BackgroundPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · cited 1×
“[23–25].”
Priller, J., Flügel, A., Wehner, T., Boentert, M., Haas, C. A., Prinz, M., Fernández-Klett, F., Prass, K., Bechmann, I., de Boer, B. A., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1356 · Cited by 637 · cited 1×
“]. Thus, bone marrow–derived myeloid cells (BM-MC) might reflect microglial precursors and may serve as a natural vehicle for CNS cell and gene therapy [”
BackgroundSelf-citationSchwab, M. E. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.01.004 · Cited by 613 · cited 1×
“Rapid clearance of myelin debris is required since components of the myelin such as Nogo prevent axonal regeneration and axonal remodeling [32].”
BackgroundMultiple sclerosis: a two-stage disease
Steinman, L. (2001) · Nature Immunology · doi:10.1038/ni0901-762 · Cited by 593 · cited 1×
“In EAE, auto-reactive CD4þ TH1 cells secrete proinflammatory cytokines such as IFNc and TNFa initiating a CNS inflammatory reaction, which is then amplified within the CNS by microglia [16,39,40].”
BackgroundBettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3299 · Cited by 556
McGeachy, M. J., Stephens, L. A., & Anderton, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3025 · Cited by 556 · cited 1×
“Furthermore, the involvement of CD4þ CD25þ regulatory T cells in the recovery from EAE can be narrowed to their production of IL-10 [36].”
BackgroundAn altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., & Kuchroo, V. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90169-8 · Cited by 412 · cited 1×
“Most experimental approaches in EAE aim at skewing the cytokine profile of myelin-specific TH cells from TH1 to TH2 by altered peptide ligands [43,44], hydroxymethyl-glutaryl coenzyme A reductase inhibitors (‘‘statins’’) [45], or DNA vaccination combined with gene delivery of interleukin-4 (IL-4) [46].”
BackgroundTickling the TCR: selective T-cell functions stimulated by altered peptide ligands
Evavold, B. D., Sloan-Lancaster, J., & Allen, P. M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90200-5 · Cited by 410 · cited 1×
“Most experimental approaches in EAE aim at skewing the cytokine profile of myelin-specific TH cells from TH1 to TH2 by altered peptide ligands [43,44], hydroxymethyl-glutaryl coenzyme A reductase inhibitors (‘‘statins’’) [45], or DNA vaccination combined with gene delivery of interleukin-4 (IL-4) [46].”
BackgroundMyelomonocytic cells are sufficient for therapeutic cell fusion in liver
Willenbring, H., Bailey, A. S., Foster, M., Akkari, Y., Dorrell, C., Olson, S., Finegold, M., Fleming, W. H., & Grompe, M. (2004) · Nature Medicine · doi:10.1038/nm1062 · Cited by 388 · cited 1×
“Isolation of myeloid precursors was performed by a modified method published by Willenbring and collaborators [19].”
MethodInnate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
Prinz, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26078 · Cited by 380 · cited 1×
“Histological examination of immune cell infiltrates, axonal injury, and demyelination was performed as described previously [20].”
MethodSelf-citationSimard, A. R., & Rivest, S. (2004) · The FASEB Journal · doi:10.1096/fj.04-1517fje · Cited by 354 · cited 1×
“Hematopoietic-derived myeloid cells physiologically migrate into the central nervous system (CNS) not only during development, but also in adulthood, and become resident perivascular macrophages and microglia [1–3].”
BackgroundSchmid, C. D., Sautkulis, L. N., Danielson, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., Sutcliffe, J. G., & Carson, M. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01243.x · Cited by 351 · cited 1×
“[21,26].”
Kotter, M. R., Zhao, C., van Rooijen, N., & Franklin, R. J. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.019 · Cited by 331 · cited 1×
“]. Particularly, macrophages appear to fulfill an important role in the clearance of tissue debris, since depletion of macrophages impairs CNS remyelination [”
BackgroundDAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318 · cited 1×
“bones, also requiring phagocytic activity [24,27].”
Developmental plasticity of CNS microglia
Santambrogio, L., Belyanskaya, S. L., Fischer, F. R., Cipriani, B., Brosnan, C. F., Ricciardi-Castagnoli, P., Stern, L. J., Strominger, J. L., & Riese, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111152498 · Cited by 309 · cited 1×
“The exact cellular subtype of myeloid precursors developing into microglia is not known, but parenchymal microglial cells have been reported to be phenotypically very similar to uncommitted myeloid precursors having ‘‘empty’’ major histocompatibility complex (MHC) class II, comparable cystein protease profiles, and th…”
BackgroundMalm, T. M., Koistinaho, M., Pärepalo, M., Vatanen, T., Ooka, A., Karlsson, S., & Koistinaho, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.009 · Cited by 301 · cited 1×
“Furthermore, it has been demonstrated that bone marrow cells are recruited to sites of axonal degeneration [4,5] or to beta-amyloid depositions in Alzheimer disease animal models [6,7] to become functional microglialike cells.”
BackgroundImpaired Differentiation of Osteoclasts in TREM-2–deficient Individuals
Cella, M., Buonsanti, C., Strader, C., Kondo, T., Salmaggi, A., & Colonna, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022220 · Cited by 242 · cited 1×
“bones, also requiring phagocytic activity [24,27].”
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 240
DAP12-Deficient Mice Fail to Develop Autoimmunity Due to Impaired Antigen Priming
Bakker, A. B. H., Hoek, R. M., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, J. H., Sedgwick, J. D., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)00034-0 · Cited by 232
Carson, M. J. (2002) · Glia · doi:10.1002/glia.10145 · Cited by 227 · cited 2×
“In this respect, myeloid precursor cells were very similar to resting microglial cells, which lack MHC class II and CD86 expression under normal conditions [16].”
BackgroundBauer, J., Sminia, T., Wouterlood, F. G., & Dijkstra, C. D. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380402 · Cited by 212 · cited 1×
“The phagocytic function of macrophages and microglia has been implicated in the removal of myelin debris during EAE [29].”
BackgroundCNS manifestations of Nasu–Hakola disease: A frontal dementia with bone cysts
Paloneva BM, J., Autti, T., Raininko, R., Partanen, J., Salonen, O., Puranen, M., Hakola, P., & Haltia, M. (2001) · Neurology · doi:10.1212/wnl.56.11.1552 · Cited by 211
Invasion of Hematopoietic Cells into the Brain of Amyloid Precursor Protein Transgenic Mice
Stalder, A. K., Ermini, F., Bondolfi, L., Krenger, W., Burbach, G. J., Deller, T., Coomaraswamy, J., Staufenbiel, M., Landmann, R., & Jucker, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2545-05.2005 · Cited by 184 · cited 1×
“Furthermore, it has been demonstrated that bone marrow cells are recruited to sites of axonal degeneration [4,5] or to beta-amyloid depositions in Alzheimer disease animal models [6,7] to become functional microglialike cells.”
BackgroundCentral Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis
Cua, D. J., Hutchins, B., LaFace, D. M., Stohlman, S. A., & Coffman, R. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.602 · Cited by 182
Flügel, A., Bradl, M., Kreutzberg, G. W., & Graeber, M. B. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1198 · Cited by 169 · cited 1×
“Furthermore, it has been demonstrated that bone marrow cells are recruited to sites of axonal degeneration [4,5] or to beta-amyloid depositions in Alzheimer disease animal models [6,7] to become functional microglialike cells.”
BackgroundHuman CD34+cells differentiate into microglia and express recombinant therapeutic protein
Asheuer, M., Pflumio, F., Benhamida, S., Dubart-Kupperschmitt, A., Fouquet, F., Imai, Y., Aubourg, P., & Cartier, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306431101 · Cited by 162 · cited 1×
“Thus, bone marrow–derived myeloid cells (BM-MC) might reflect microglial precursors and may serve as a natural vehicle for CNS cell and gene therapy [2,10].”
BackgroundPathogenesis of multiple sclerosis
Prat, A., & Antel, J. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000169737.99040.31 · Cited by 158
Zamvil, S. S., & Steinman, L. (2003) · Neuron · doi:10.1016/s0896-6273(03)00326-x · Cited by 149 · cited 1×
“In EAE, auto-reactive CD4þ TH1 cells secrete proinflammatory cytokines such as IFNc and TNFa initiating a CNS inflammatory reaction, which is then amplified within the CNS by microglia [16,39,40].”
BackgroundRemodeling of Axonal Connections Contributes to Recovery in an Animal Model of Multiple Sclerosis
Kerschensteiner, M., Bareyre, F. M., Buddeberg, B. S., Merkler, D., Stadelmann, C., Brück, W., Misgeld, T., & Schwab, M. E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040452 · Cited by 149 · cited 1×
“Axonal remodeling has been shown to contribute to recovery and repair in EAE [33].”
BackgroundGarren, H., Ruiz, P. J., Watkins, T. A., da Fontoura, P. P., Nguyen, L.-V. T., Estline, E. R., Hirschberg, D. L., & Steinman, L. (2001) · Immunity · doi:10.1016/s1074-7613(01)00171-6 · Cited by 137 · cited 4×
“Most experimental approaches in EAE aim at skewing the cytokine profile of myelin-specific TH cells from TH1 to TH2 by altered peptide ligands [43,44], hydroxymethyl-glutaryl coenzyme A reductase inhibitors (‘‘statins’’) [45], or DNA vaccination combined with gene delivery of interleukin-4 (IL-4) [46].”
BackgroundInfluentialBechmann, I., Goldmann, J., Kovac, A. D., Kwidzinski, E., Simbürger, E., Naftolin, F. N., Dirnagl, U., Nitsch, R., & Priller, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2599fje · Cited by 129 · cited 1×
“Furthermore, it has been demonstrated that bone marrow cells are recruited to sites of axonal degeneration [4,5] or to beta-amyloid depositions in Alzheimer disease animal models [6,7] to become functional microglialike cells.”
BackgroundFlt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia
Delprat, C., Arnaud, S., Jurdic, P., Nataf, S., Grasset, M.-F., Soulas, C., Domenget, C., Destaing, O., Rivollier, A., Perret, M., et al. (2002) · BMC Immunology · doi:10.1186/1471-2172-3-15 · Cited by 101 · cited 1×
“The exact cellular subtype of myeloid precursors developing into microglia is not known, but parenchymal microglial cells have been reported to be phenotypically very similar to uncommitted myeloid precursors having ‘‘empty’’ major histocompatibility complex (MHC) class II, comparable cystein protease profiles, and th…”
BackgroundMechanisms of CNS remyelination—the key to therapeutic advances
Zhao, C., Fancy, S. P. J., Kotter, M., Li, W., & Franklin, R. J. M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.008 · Cited by 88 · cited 1×
“Particularly, macrophages appear to fulfill an important role in the clearance of tissue debris, since depletion of macrophages impairs CNS remyelination [30,31].”
BackgroundJander, S., Pohl, J., D’Urso, D., Gillen, C., & Stoll, G. (1998) · Europe PMC (PubMed Central) · Cited by 74
Multiple sclerosis: trapped in deadly glue
Platten, M., & Steinman, L. (2005) · Nature Medicine · doi:10.1038/nm0305-252 · Cited by 74 · cited 1×
“Furthermore, the microglial cytokine milieu determines the outcome of the inflammatory process in the animal model of MS, experimental autoimmune encephalomyelitis (EAE) [16–18].”
BackgroundMatsuo, A., Lee, G. C., Terai, K., Takami, K., Hickey, W. F., McGeer, E. G., & McGeer, P. L. (1997) · Europe PMC (PubMed Central) · Cited by 71
β 1 integrin activation on human neutrophils promotes β 2 integrin-mediated adhesion to fibronectin
van den Berg, J. M., Mul, E. P. J., Schippers, E., Weening, J. J., Roos, D., & Kuijpers, T. W. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1<276::aid-immu276>3.0.co;2-d · Cited by 68
Self-citationAcute axonal damage predicts clinical outcome in patients with multiple sclerosis
Lim, E. T., Sellebjerg, F. T., Jensen, C. V., Altmann, D. R., Grant, D., Keir, G., Thompson, E. J., & Giovannoni, G. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1218oa · Cited by 44 · cited 1×
“This secondary progressive neurodegenerative phase, particularly with axonal tissue loss, appears to be resistant to anti-inflammatory therapies and predicts the clinical outcome in MS patients [41,42].”
BackgroundBettelli, E., Das, M. P., Howard, E. D., Weiner, H. L., Sobel, R. A., & Kuchroo, V. K. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)91500-4 · Cited by 18 · cited 1×
“because remission is impaired in IL-10–deficient mice [35].”
Arnold, D. L. (2005) · Journal of Neurology · doi:10.1007/s00415-005-5005-4 · Cited by 17 · cited 1×
“This secondary progressive neurodegenerative phase, particularly with axonal tissue loss, appears to be resistant to anti-inflammatory therapies and predicts the clinical outcome in MS patients [41,42].”
Background
Research works printed but not linked: 49
- Hickey, 1988, Science, 239, 290
- Priller, 2001, Nat Med, 7, 1356
- Simard, 2004, FASEB J, 18, 998
- Flugel, 2001, J Neurosci Res, 66, 74
- Bechmann, 2005, FASEB J, 19, 647
- Malm, 2005, Neurobiol Dis, 18, 134
- Stalder, 2005, J Neurosci, 25, 11125
- Santambrogio, 2001, Proc Natl Acad Sci U S A, 98, 6295
- Servet-Delprat, 2002, BMC Immunol, 3, 15
- Asheuer, 2004, Proc Natl Acad Sci U S A, 101, 3557
- Voll, 1997, Nature, 390, 350
- Savill, 2002, Nat Rev Immunol, 2, 965
- Serhan, 2005, Nat Immunol, 6, 1191
- Takahashi, 2005, J Exp Med, 201, 647
- Prat, 2005, Curr Opin Neurol, 18, 225
- Carson, 2002, Glia, 40, 218
- Heppner, 2005, Nat Med, 11, 146
- Platten, 2005, Nat Med, 11, 252
- Willenbring, 2004, Nat Med, 10, 744
- Prinz, 2006, J Clin Invest, 116, 456
- Colonna, 2003, Nat Rev Immunol, 3, 445
- Matsuo, 1997, Am J Pathol, 150, 1253
- Paloneva, 2001, Neurology, 56, 1552
- Paloneva, 2003, J Exp Med, 198, 669
- Paloneva, 2002, Am J Hum Genet, 71, 656
- Schmid, 2002, J Neurochem, 83, 1309
- Cella, 2003, J Exp Med, 198, 645
- Turnbull, 2006, J Immunol, 177, 3520
- Bauer, 1994, J Neurosci Res, 38, 365
- Kotter, 2005, Neurobiol Dis, 18, 166
- Zhao, 2005, J Neurol Sci, 233, 87
- Schwab, 2004, Curr Opin Neurobiol, 14, 118
- Kerschensteiner, 2004, J Exp Med, 200, 1027
- Jander, 1998, Am J Pathol, 152, 975
- Bettelli, 1998, J Immunol, 161, 3299
- McGeachy, 2005, J Immunol, 175, 3025
- Cua, 2001, J Immunol, 166, 602
- Bakker, 2000, Immunity, 13, 345
- Steinman, 2001, Nat Immunol, 2, 762
- Zamvil, 2003, Neuron, 38, 685
- Arnold, 2005, J Neurol, 252, v25
- Lim, 2005, Mult Scler, 11, 532
- Evavold, 1993, Immunol Today, 14, 602
- Nicholson, 1995, Immunity, 3, 397
- Youssef, 2002, Nature, 420, 78
- Garren, 2001, Immunity, 15, 15
- Flugel, 2001, Eur J Immunol, 31, 11
- Pluchino, 2003, Nature, 422, 688
- Pluchino, 2005, Nature, 436, 266
Cited by
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
“Neumann and colleagues (72) have shown that microglia express TREM2 (triggering receptor expressed on myeloid cells-2) and that this receptor is involved in the phagocytosis of debris and downregulation of proinflammatory cytokine expression.”
BackgroundTREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
“Why is TREM2 activated during Aβ accumulation? Previous studies have indicated that TREM2 binds phospholipids, such as PS, and acts as a scavenger receptor for apoptotic cells that might be generated during neuronal damage (Hsieh et al., 2009; Takahashi et al., 2007; Takahashi et al., 2005).”
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329
Self-citation
Metadata
- Authors
- Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H.
- Affiliations
- University of Bonn (DE)
- Universitätsmedizin Göttingen (DE)
- Corresponding author
- Neumann, Harald
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-04-10
- Volume
- 4
- Issue
- 4
- Pages
- e124
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1851623
- OpenAlex
- W2116226263
- Cited by
- 414
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 28 · 2023: 18 · 2022: 19 · 2021: 22 · 2020: 19 · 2019: 23 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 35 · 2014: 32 · 2013: 34 · 2012: 16
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 704)
- Gemeinnützige Hertie-Stiftung
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- TREM2, multiple sclerosis, experimental autoimmune encephalomyelitis, myeloid precursors, microglia, phagocytosis, myelin debris clearance, demyelination, axonal injury, neuroinflammation, neurorepair, gene therapy, bone marrow-derived cells, anti-inflammatory cytokines
- MeSH terms
- Animals, Cell Differentiation, Cell Movement, Cells, Cultured, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Female, Flow Cytometry, Gene Expression Regulation, Genes, Synthetic, Genetic Vectors, Humans, Membrane Glycoproteins, Mice, Inbred C57BL, Monocytes, Multiple Sclerosis, Neurons, Phagocytosis, Promoter Regions, Genetic, Receptors, Immunologic, Transduction, Genetic, Genetic Therapy, Lentivirus, Granulocyte-Macrophage Colony-Stimulating Factor, Cytokines, Interleukin-10, Apoptosis, Microglia, Genes, Reporter, Hematopoietic Stem Cell Transplantation, Cell Lineage, Myeloid Cells, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.